TTP LabTech Launches New High-Content Contract Screening Service
Want to listen to this article for FREE?
Complete the form below to unlock access to ALL audio articles.
Read time: Less than a minute
TTP LabTech has launched its new contract screening service based around the company’s HCS technology, the Acumen® microplate cytometer. The service will provide clients with high-content data using cell-based assays for the investigation of various biological phenomena - including cell cycle, RNAi profiling, angiogenesis and signal pathway profiling.
The new service complements TTP LabTech’s existing product business by providing companies with an easy route into high-content screening. Initially run from TTP LabTech’s headquarters in the UK, the service is currently available in two forms, Standard and Full.
The Standard Service offering, includes the rapid scanning and analysis of pre-prepared experimental plates whilst the more extensive Full Service incorporates the entire process from cell culture, through compound/reagent treatment, to screening, analysis and data reporting, and can include assay development where required.
The new service complements TTP LabTech’s existing product business by providing companies with an easy route into high-content screening. Initially run from TTP LabTech’s headquarters in the UK, the service is currently available in two forms, Standard and Full.
The Standard Service offering, includes the rapid scanning and analysis of pre-prepared experimental plates whilst the more extensive Full Service incorporates the entire process from cell culture, through compound/reagent treatment, to screening, analysis and data reporting, and can include assay development where required.
